From menarche to menopause: a lifespan perspective on women's health in sickle cell disease
- 1University of Illinois Chicago, Division of Hematology & Oncology , , ,
- 2University of Chicago, Department of Obstetrics and Gynecology , , ,
- 3University of Miami Health System, Department of Obstetrics and Gynecology , , ,
Abstract
Sickle cell disease (SCD) has long been associated with high childhood mortality and reduced life expectancy; however, advances in newborn screening, disease-modifying therapies, and comprehensive care have substantially improved survival. As increasing numbers of women with SCD reach midlife, new challenges are emerging that extend beyond the traditional focus on fertility and pregnancy. Despite growing recognition of reproductive health issues in SCD, menopause remains an underexplored and underrecognized phase of the disease trajectory. In this Perspective, we propose a lifespan framework for women's health in SCD that extends from menarche through menopause and healthy aging. We discuss how the underlying pathophysiology of SCD—including chronic hemolysis, inflammation, endothelial dysfunction, and progressive organ injury—intersects with reproductive transitions across the female life course. We highlight emerging evidence suggesting earlier menopause in women with SCD and examine the potential implications for pain burden, cognitive health, bone health, cardiovascular risk, iron overload, and quality of life. We further explore how symptom overlap between menopause and SCD may contribute to underdiagnosis and undertreatment during midlife. At the same time, we highlight the role of protective factors—including comprehensive multidisciplinary care, the development and evaluation of menopause-specific interventions through dedicated clinical trials in individuals with SCD, reproductive health services, and coordinated lifespan care models—in supporting healthy aging and improving long-term outcomes. Finally, we argue that menopause should be recognized as a critical component of comprehensive SCD care and research. Integrating reproductive aging into clinical practice, research agendas, and health policy represents an important opportunity to improve lifelong health outcomes, strengthen women-centered care, and advance health equity for women living with SCD worldwide.
Related
- Female Sexual Dysfunction Across the Female Lifespan: The Impact of Menopause, Pelvic Floor Disorders, and Pelvic Surgery
- Correlation Between the Age at Menarche, Time to Diagnosis, and Disease Severity Assessed Using the rASRM and #ENZIAN Classifications in Patients Diagnosed with Advanced Endometriosis
- Digitalized “preventive treatment” in chronic disease control and proactive health: a perspective on integrating TCM wisdom with digital intelligence
- Study of Menopause and Resistance Training for Brain Health (SMART brain): a randomized controlled trial
- Heterogeneity in proteomic risk factors for coronary heart disease by sex and menopause status
BibTeX
@article{farooqui2026from,
title = {{From menarche to menopause: a lifespan perspective on women's health in sickle cell disease}},
author = {Marwah Farooqui and Monica Christmas and Gelila Goba and Lewis Hsu},
journal = {Frontiers in epidemiology},
year = {2026},
month = oct,
doi = {10.3389/fepid.2026.1931488},
url = {https://europepmc.org/article/PMC/PMC13719543},
note = {CC BY},
}
RIS
TY - JOUR
TI - From menarche to menopause: a lifespan perspective on women's health in sickle cell disease
AU - Marwah Farooqui
AU - Monica Christmas
AU - Gelila Goba
AU - Lewis Hsu
PY - 2026
DA - 2026/10/16
JO - Frontiers in epidemiology
DO - 10.3389/fepid.2026.1931488
UR - https://europepmc.org/article/PMC/PMC13719543
AB - Sickle cell disease (SCD) has long been associated with high childhood mortality and reduced life expectancy; however, advances in newborn screening, disease-modifying therapies, and comprehensive care have substantially improved survival. As increasing numbers of women with SCD reach midlife, new challenges are emerging that extend beyond the traditional focus on fertility and pregnancy. Despite growing recognition of reproductive health issues in SCD, menopause remains an underexplored and underrecognized phase of the disease trajectory. In this Perspective, we propose a lifespan framework for women's health in SCD that extends from menarche through menopause and healthy aging. We discuss how the underlying pathophysiology of SCD—including chronic hemolysis, inflammation, endothelial dysfunction, and progressive organ injury—intersects with reproductive transitions across the female life course. We highlight emerging evidence suggesting earlier menopause in women with SCD and examine the potential implications for pain burden, cognitive health, bone health, cardiovascular risk, iron overload, and quality of life. We further explore how symptom overlap between menopause and SCD may contribute to underdiagnosis and undertreatment during midlife. At the same time, we highlight the role of protective factors—including comprehensive multidisciplinary care, the development and evaluation of menopause-specific interventions through dedicated clinical trials in individuals with SCD, reproductive health services, and coordinated lifespan care models—in supporting healthy aging and improving long-term outcomes. Finally, we argue that menopause should be recognized as a critical component of comprehensive SCD care and research. Integrating reproductive aging into clinical practice, research agendas, and health policy represents an important opportunity to improve lifelong health outcomes, strengthen women-centered care, and advance health equity for women living with SCD worldwide.
SN - 2674-1199
ER -